Screener
Pacific Biosciences of California PACB Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $62.61M+10.5% | $57.86M-4.7% | $65.26M+13.3% | $58.3M-27.3% | $56.64M-44.4% | ||
| $175.87M-32.3% | $219.69M-22.8% | $215.8M-35.5% | $242.19M-38.4% | $259.93M-36.6% | ||
| $31.1M-3.6% | $29.35M-7.3% | $35.45M+28.8% | $30.62M+4.2% | $32.26M-0.5% | ||
| $61.08M-30.3% | $79.92M-3.5% | $81.4M-0.2% | $83.41M+26.9% | $87.63M+27.7% | ||
| $338.64M-18.1% | $369.52M-16.9% | $375.05M-24.3% | $394.24M-32.5% | $413.4M-34.2% | ||
| $26.97M+16.8% | $24.38M-1.7% | $24.15M-20.8% | $22.13M-30.7% | $23.1M-33.8% | ||
| $317.76M0.0% | $317.76M0.0% | $317.76M0.0% | $317.76M-13.9% | $317.76M-13.9% | ||
| $13.08M-23.8% | $14.1M-22.4% | $15.12M-96.1% | $16.14M-95.8% | $17.16M-95.6% | ||
| $751.85M-8.9% | $782.37M-9.1% | $784.08M-37.8% | $803.16M-44.6% | $825.47M-45.3% | ||
| $19.22M+27.7% | $13.61M-3.0% | $20.77M+25.2% | $16.36M+35.6% | $15.06M-13.9% | ||
| $16.1M+8.3% | $16.33M+7.1% | $15.94M+14.9% | $16.05M-7.2% | $14.86M-22.6% | ||
| $68.81M+15.1% | $65.36M-1.9% | $72.83M+9.9% | $63.21M+5.4% | $59.75M-23.8% | ||
| $785.06M— | $780M— | $778.73M+4,064% | $0-100% | $0-100% | ||
| 1B0.0% | 1B0.0% | 1B+340,036% | 1B0.0% | 1B0.0% | ||
| -$2.75B-5.0% | -$2.7B-5.0% | -$2.7B-25.4% | -$2.65B-23.4% | -$2.62B-25.2% | ||
| -$33.21M-154% | $2.37M-97.4% | $5.35M-98.9% | $36.09M-92.0% | $61.49M-87.5% | ||
| $751.85M-8.9% | $782.37M-9.1% | $784.08M-37.8% | $803.16M-44.6% | $825.47M-45.3% |
FAQ
- What are Pacific Biosciences of California's total assets?
- Pacific Biosciences of California (PACB) holds $751.9M in total assets, down 8.9% year over year.
- How much debt does Pacific Biosciences of California have?
- Pacific Biosciences of California carries $61.8M in total debt against -$33.2M of shareholders' equity, a debt-to-equity ratio of 25.06.
- How much cash does Pacific Biosciences of California have?
- Pacific Biosciences of California holds $62.6M in cash and equivalents.
- Can Pacific Biosciences of California cover its short-term obligations?
- Its current ratio is 4.92 — current assets exceed current liabilities.
- Where does Pacific Biosciences of California's balance sheet data come from?
- Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
